Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Martin Hale

Orthopaedic Surgery Plantation, FL Medical Doctor

NPI 1073504833 CMS profile 184304

499 Nw 70Th Ave, Suite 200, Plantation, FL 33317

Open in the dashboard

General payments

$63,418

296 records reported · program years 2019–2025

Research payments

$108,167

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,886,848 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Martin Hale of Plantation, FL is reported in the CMS Open Payments database as having received $63,418 across 296 general payments and $108,167 in research payments paid to them. Separately, studies naming them as principal investigator received $2,886,848 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $21,149 18
2022 General $270 5
2021 General $18,518 47
2021 Research $1,297 1
2020 General $7,352 71
2020 Research $106,870 4
2019 General $16,129 155

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Martin Hale
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Martin Hale were reported at $21,149. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Martin Hale Orthopaedic Surgery median Middle half National median
2019 $16,129 $644 $140–$2,844 $163
2020 $7,352 $312 $75–$1,860 $114
2021 $18,518 $520 $117–$2,495 $132
2022 $270 $598 $128–$2,731 $149
2023 $0 $461 $128–$2,264 $160
2024 $0 $497 $134–$2,475 $164
2025 $21,149 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Vertex Pharmaceuticals Incorporated $13,621 8 payments
  2. Shionogi Inc $13,577 23 payments
  3. RedHill Biopharma Inc. $12,711 26 payments
  4. Biodelivery Sciences International, Inc. $10,887 33 payments
  5. Merck Sharp & Dohme Corporation $7,528 10 payments
  6. US WorldMeds, LLC $1,467 13 payments
  7. Collegium Pharmaceutical, Inc. $1,086 43 payments
  8. AbbVie, Inc. $520 16 payments
  9. Salix Pharmaceuticals, a division of Bausch Health US, LLC $396 33 payments
  10. Horizon Therapeutics plc $285 11 payments
  11. Other $1,340 80 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $31,733 18 payments
  2. Consulting Fee $9,399 3 payments
  3. Travel and Lodging $9,070 29 payments
  4. Food and Beverage $7,208 242 payments
  5. Honoraria $6,000 2 payments
  6. Education $8 2 payments
Products named General payments · program years 2019–2025
  1. JOURNAVX $13,621 8 payments
  2. Symproic Gastroenterology $13,577 23 payments
  3. Movantik $12,711 26 payments
  4. BELBUCA Addiction Therapy $5,279 10 payments
  5. BELBUCA Chronic Pain $4,492 7 payments
  6. Lucemyra/Lofexidine $1,467 13 payments
  7. XTAMPZA $948 41 payments
  8. SYMPROIC Addiction Therapy $942 4 payments
  9. UBRELVY $509 15 payments
  10. RELISTOR $342 32 payments
  11. Other $2,945 152 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Eli Lilly and Company $108,167 5 payments

Records

301 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record